Literature DB >> 22523145

Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 2: C-reactive protein in the diagnosis of bacteraemia.

Amy Au-Yong1.   

Abstract

A short-cut review was carried out to establish the sensitivity and specificity of CRP as a tool for diagnosing bacteraemia. Three studies were directly relevant to the question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these papers are tabulated. The clinical bottom line suggests that CRP is not a useful tool in the initial diagnosis of severe bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22523145     DOI: 10.1136/emermed-2012-201302.3

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  4 in total

1.  Non-culture-based methods to diagnose bloodstream infection: Does it work?

Authors:  Miha Skvarc; David Stubljar; Petra Rogina; Achim J Kaasch
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-06-05

2.  Diagnostic and prognostic value of sCD14-ST--presepsin for patients admitted to hospital intensive care unit (ICU).

Authors:  Matej Godnic; David Stubljar; David Stubjar; Miha Skvarc; Tomislav Jukic
Journal:  Wien Klin Wochenschr       Date:  2015-04-09       Impact factor: 1.704

3.  Clinical Value of Presepsin in Comparison to hsCRP as a Monitoring and Early Prognostic Marker for Sepsis in Critically Ill Patients.

Authors:  Elham A Hassan; Abeer S Abdel Rehim; Asmaa O Ahmed; Hanan Abdullahtif; Alaa Attia
Journal:  Medicina (Kaunas)       Date:  2019-02-02       Impact factor: 2.430

4.  Could Neutrophil CD64 Expression Be Used as a Diagnostic Parameter of Bacteremia in Patients with Febrile Neutropenia?

Authors:  Nur Efe İris; Taner Yıldırmak; Habip Gedik; Funda Şimşek; Demet Aydın; Naciye Demirel; Osman Yokuş
Journal:  Turk J Haematol       Date:  2016-06-27       Impact factor: 1.831

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.